Inovio Product Pipeline: Infectious Disease DNA Vaccines

Inovio has multiple partners working at various stages of pre-clinical and clinical development on DNA immunotherapies, or more specifically, DNA vaccines, targeting a broad scope of chronic infectious diseases. This emerging, next generation of vaccines represents a promising new alternative for preventing AND treating infectious diseases such as HIV and hepatitis C virus, devastating diseases affecting millions of people.

The following sections present the clinical and pre-clinical programs currently underway involving DNA vaccines delivered using Inovio's DNA delivery technology.